Lymphocyte capping in limb-girdle muscular dystrophy: Patients and carriers in an amish isolate
β Scribed by Bader, Patricia I. ;Bender, Cynthia J. ;Creason, Marilyn T. ;Conn, Patricia S. ;Townsend, Douglas W.
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 808 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Communicated by Mireille Claustres Limb girdle muscular dystrophies (LGMD) are characterized by genetic and clinical heterogeneity: seven autosomal dominant and 12 autosomal recessive loci have so far been identified. Aims of this study were to evaluate the relative proportion of the different
We describe a couple of siblings who have a homozygous mutation in the β£-sarcoglycan gene and present a striking clinical difference in their phenotype; the brother is asymptomatic, and the sister is affected with mild limb-girdle muscular dystrophy. Drug therapy with a new steroid (deflazacort) was
We report on the clinical, pathological, and genetic features of 7 patients with limb-girdle muscular dystrophy type 2A (LGMD2A) from three Japanese families. The mean age of onset was 9.7 Β± 3.1 years (mean Β± SD), and loss of ambulance occurred at 38.5 Β± 2.1 years. Muscle atrophy was predominant in